Breast Cancer Facts & Figures 2024-2025

Contents

• Fast Facts
• Introduction
• Tables and Figures
• American Cancer Society Recommendations for Breast Cancer Screening
• American Cancer Society Programs, Research, and Advocacy
• Data Methods and Limitations
• References

Fast Facts

• About 1 in 8 women in the US will be diagnosed with invasive breast cancer, and 1 in 43 will die from it.
• Breast cancer mortality has declined in every racial and ethnic group since 1990, except for American Indian/Alaska Native women.
• In 2024, an estimated 310,720 new invasive breast cancers and 56,500 cases of ductal carcinoma in situ will be diagnosed among women in the US.
• The 5-year relative survival rate for breast cancer is 91%, but drops to 86% at 10 years and 81% at 15 years after diagnosis.

Introduction

• Breast cancer is the most common cancer diagnosed among women in the US.
• Breast cancer incidence increases with age until the seventh decade of life and then decreases.
• Black women have the highest incidence of breast cancer until 40 years of age, and White women have the highest incidence in ages 65-84 years.
• Hispanic women have the lowest incidence of breast cancer from age 30 to 59 years, and Asian American/Pacific Islander women have the lowest incidence thereafter.

Tables and Figures

• Table 1: Ten-year Probability of Breast Cancer Diagnosis and Death by Age.
• Figure 1: Age-specific Female Breast Cancer Incidence Rates by Race and Ethnicity, US, 2017-2021.
• Table 2: Estimated Number of Female Ductal Carcinoma In Situ and Invasive Breast Cancer Cases and Deaths by Age, US, 2024.
• Figure 2: Trends in Incidence of Ductal Carcinoma In Situ and Invasive Female Breast Cancer by Age, US, 1975-2021.
• Table 3: Factors That Increase Risk of Invasive Female Breast Cancer.
• Table 4: Breast Cancer Subtypes and Distributions, US, 2017-2021.
• Figure 3: Distribution of Breast Cancer Subtypes by Race and Ethnicity, US, 2017-2021.
• Figure 4: Female Breast Cancer Incidence and Death Rates by Race and Ethnicity, US.
• Figure 5: Trends in Female Breast Cancer Incidence Rates by Race and Ethnicity, US, 1998-2021.
• Figure 6: Trends in Female Breast Cancer Death Rates by Race and Ethnicity, US, 1975-2022.
• Figure 7: Trends in Female Breast Cancer 5-year Relative Survival Rates (%) by Race, US, 1975-2020.
• Figure 8: Female Breast Cancer Stage Distribution by Race and Ethnicity, US, 2017-2021.
• Figure 9: Five-year Relative Survival Rates (%) by Stage at Diagnosis and Race and Ethnicity, US, 2014-2020.
• Table 5: State-level Breast Cancer Incidence and Death Rates by Race and Ethnicity, US.
• Figure 10: Male Breast Cancer Statistics, US.
• Table 6: Mammography Prevalence (%), Women 40 and Older, US, 2021.
• Figure 11: Mammography Prevalence (%) in the Past Two Years by State, Women 40 and Older, 2022.

American Cancer Society Recommendations for Breast Cancer Screening

• Women at average risk should begin annual mammography at age 40.
• Women at high risk should begin annual screening with MRI and mammography at age 30.

American Cancer Society Programs, Research, and Advocacy

• The American Cancer Society invests in breast cancer research and provides support and resources for patients and caregivers.
• The ACS Cancer Action Network (ACS CAN) advocates for cancer research funding and improved access to cancer screening and treatment.

Data Methods and Limitations

• The report includes data on invasive breast cancer cases and deaths in the US.
• Data methods include spatiotemporal modeling, age-adjustment, and trend analysis.
• Limitations include potential variations in data due to changes in cancer occurrence and reporting delays.

References

• The report provides a list of references for further reading and information.